Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Deresinski

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2022
OXA-48, AmpC, or Both-Activity of Some Newer ß-LactamsStan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2012
Methicillin-resistant Staphylococcus aureus and vancomycin: minimum inhibitory concentration mattersStan Deresinski
International Journal of Antimicrobial Agents|November 26, 2009
Antibiotic therapy of vascular catheter-related bloodstream infections: is vancomycin the optimal choice for Staphylococcus aureus infections?Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2007
Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical dataStan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2009
Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infectionsStan Deresinski
Expert Review of Anti-Infective Therapy|June 6, 2007
Vancomycin: does it still have a role as an antistaphylococcal agent?Stan Deresinski
AIDS Alert|April 17, 2008
Screening for abacavir hypersensitivityStan Deresinski
Drugs|October 17, 2006
Antistaphylococcal vaccines and immunoglobulins: current status and future prospectsStan Deresinski
The Journal of Infectious Diseases|March 30, 2013
The multiple paths to heteroresistance and intermediate resistance to vancomycin in Staphylococcus aureusStan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2010
Guiding clinical care through evidence-free zonesStan Deresinski
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2022
OXA-48, AmpC, or Both-Activity of Some Newer ß-LactamsStan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2012
Methicillin-resistant Staphylococcus aureus and vancomycin: minimum inhibitory concentration mattersStan Deresinski
International Journal of Antimicrobial Agents|November 26, 2009
Antibiotic therapy of vascular catheter-related bloodstream infections: is vancomycin the optimal choice for Staphylococcus aureus infections?Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2007
Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical dataStan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2009
Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infectionsStan Deresinski
Expert Review of Anti-Infective Therapy|June 6, 2007
Vancomycin: does it still have a role as an antistaphylococcal agent?Stan Deresinski
AIDS Alert|April 17, 2008
Screening for abacavir hypersensitivityStan Deresinski
Drugs|October 17, 2006
Antistaphylococcal vaccines and immunoglobulins: current status and future prospectsStan Deresinski
The Journal of Infectious Diseases|March 30, 2013
The multiple paths to heteroresistance and intermediate resistance to vancomycin in Staphylococcus aureusStan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2010
Guiding clinical care through evidence-free zonesStan Deresinski
Pageof 7